Insights On Trial Design
-
How Master Protocols Are Accommodating Trial Advances
6/7/2023
As a result of trial design changes in the life sciences industry, learn what drug developers are doing to keep pace with the ongoing advancements in genomics, immunology, and precision medicine.
-
Non-Alcoholic Steatohepatitis (NASH): Asia Pacific Clinical Trial Landscape
9/29/2022
Even though NAFLD (non-alcoholic fatty liver disease) is a significant public health burden in the United States and Europe, learn why Asia has a NAFLD burden that is increasing faster than the developed countries of the West.
-
Clinical Research Considerations For Rare Disease Patients: Part 1 — Reinvigorate Patient Centricity
8/15/2022
Rare disease protocol design, vendor selection, patient recruitment and retention, and site and patient qualification can be undermined by several factors, but common-sense initiatives can improve both patient experience and sponsor initiatives.
-
3 Years Later: How Hard It Was To Develop And Research A COVID-19 Vaccine
3/16/2023
Unearth some of the challenges and prospects faced by clinical trial teams working on vaccine development against COVID-19.
-
Solid Tumors: Asia Pacific Clinical Trial Landscape
9/29/2022
Read more about how the large population and lower volume of studies decreases competing trial risk in this region with a great need for novel drug therapies for solid tumors in Asian patients
-
Sikich SuiteSuccess For Life Sciences Product Tour
2/3/2023
See how SuiteSuccess for Life Sciences addresses the unique financial, contract, compliance, and reporting needs of life sciences companies, delivering everything you need to succeed in as little as eight weeks.
-
Why In The World Should You Come To San Diego?
4/19/2024
With over 180 sessions across 13 tracks and nine engaging learning formats, attendees will delve into emerging fields such as precision medicine, regulatory CMC, and product quality, and value-based access.
-
The Stories And Statistics Behind Breast Cancer: Part Two
2/15/2023
In part two of a survivor series, several individuals who beat breast cancer, and their loved ones, discuss the challenges and treatments they underwent while fighting the disease.
-
The Pharmaceutical Industry: 2024 (And Beyond) Predictions
1/24/2024
DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.
-
Supporting A Sponsor From SPA Rejection To BLA Submission
8/22/2022
Learn how the clinical trial design and the statistical foundation of the special protocol assessment (SPA), which helped drive to regulatory agreement, was transformed in this case study.